Patents

1.

1/12/16 – Received US Patent US 9,233,119 B2 entitled:

USE OF HMGA-TARGETED PHOSPHOROTHIOATE DNA APTAMERS TO SUPPRESS CARCINOGENIC ACTIVITY AND INCREASE SENSITIVITY TO CHEMOTHERAPY AGENTS IN HUMAN CANCER CELLS

 

Applicant – Miami University

Inventor – Michael A. Kennedy

 

2.

7/20/16 - Received notice of allowance for US Divisional Patent Application No. 14/951887 entitled:

USE OF HMGA-TARGETED PHOSPHOROTHIOATE DNA APTAMERS TO SUPPRESS CARCINOGENIC ACTIVITY AND INCREASE SENSITIVITY TO CHEMOTHERAPY AGENTS IN HUMAN CANCER CELLS

 

Applicant – Miami University

Inventor – Michael A. Kennedy


Comments